NCT06832982 2026-04-09
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
Shanghai Pushi Medical Science Co. Ltd
Phase 1 Recruiting
Shanghai Pushi Medical Science Co. Ltd
Coherus Oncology, Inc.
Coherus Oncology, Inc.
Sichuan University